Groowe Groowe / Newsroom / VVOS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VVOS News

Vivos Therapeutics, Inc. Common Stock

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

globenewswire.com
VVOS

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

globenewswire.com
VVOS

Form 8-K

sec.gov
VVOS

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics

accessnewswire.com
VTIX NTHI MDCX YYGH VVOS DVLT ACXP IGC CAST

Form 8-K

sec.gov
VVOS

Vivos Therapeutics Reports Full Year 2025 Financial Results

globenewswire.com
VVOS

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

globenewswire.com
VVOS

New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)

accessnewswire.com
MDCX SDST VTIX VVOS YYGH DVLT CISO LTRN CAST

New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)

accessnewswire.com
IGC VVOS ACXP EQX DVLT CISO VTIX NRXP

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

globenewswire.com
VVOS